Product
mRNA vaccine booster dose
1 clinical trial
6 indications
Indication
Kidney DiseasesIndication
Kidney TransplantIndication
COVID-19Indication
Adverse Vaccine ReactionIndication
Acute Renal RejectionIndication
Chronic Renal FailureClinical trial
Assessment of Association Between 3rd Dose of mRNA Vaccine and Risk of SARS-CoV-2 Infection in Kidney Transplant Recipients, Safety and Immunogenicity Assessment.Status: Active (not recruiting), Estimated PCD: 2024-12-04